Sawai Pharmaceutical Co., Ltd. To Take Over Three Ethical Products From Nihon Schering K. K.
10/19/2005 5:09:05 PM
Tokyo (JCN) - Sawai Pharmaceutical (TSE: 4555) announced on August 2 that it will take over the production and sales operations for three ethical products from Nihon Schering. They are blood coagulation inhibitor Caprocin Inj., gastrointestinal tract stabilizers Coreminal Tab. and Coreminal Fine granule, and antiparkinson drug Bicamol Tab.
comments powered by